FDA Week - 03/20/2020

FDA Eyes Compassionate Use, Expanded Indications For COVID-19 Drugs

By Beth Wang / March 19, 2020 at 3:30 PM
FDA hopes to use its compassionate use program to get potential COVID-19 therapies to health care providers and patients while also gathering information on safety and efficacy, agency chief Stephen Hahn announced Thursday (March 19) during a White House press briefing. Hahn and President Donald Trump both asserted the value of using the agency’s compassionate use program, also known as Expanded Access, over the Right to Try path saying it will allow the agency to collect more data on potential...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.